Our Mission

We provide data researchers of all levels with an easy-to-use, cloud-based visual data mining platform that enables real-time analysis of complex health data.

Our mission is simple: We seek to democratize health data research, making it easier to access, analyze and understand patterns in health and health care. We believe this simple mission can enable powerful changes in how we understand, treat and prevent disease around the world.

Join us on our mission, and use our powerful data exploration tools to illuminate how your healthcare data universe really works.

Key People

Simon Fitall

Simon Fitall

Co-Founder

Simon is a knowledge engineer with 30 years experience in market research, data analytics and business intelligence within the pharmaceutical, biotechnology and medical device industries.

Anna McCollister-Slipp

Anna McCollister-Slipp

Co-Founder

Anna is the co-founder of Galileo Analytics, a visual data exploration and advanced data analytics company focused on democratizing access to and understanding of complex health data.

Paul Grosvenor

Paul Grosvenor

Co-Founder & CTO

Paul is the Chief Technology Architect at Galileo. He has more than 30 years experience in data systems design and management. His specific expertise is focused on creating data system architectures.

Gilgamesh Athoraya

Gilgamesh Athoraya

Lead Programmer

Gilgamesh is the lead programmer at Galileo Analtyics, playing a key role in each and every aspect of the design and implementation of the Galileo Cosmos™ system.

Latest News

Discovering the patient cohorts that make the difference

| News | No Comments
Complex patient analysis – discovering the patient cohorts that make the difference (part 3) Patients are very complex things to analyse and unfortunately most of our analyses don’t touch on...

A unique tool for data analysis in healthcare

| News | No Comments
What makes Galileo Cosmos™ unique? A client recently asked for a simple graphic that represented their core target patient population. Easy, you say; but unfortunately this particular patient population is...

Precision Medicine Initiative and its Effect on Data Analysis

| Presentations | No Comments
Precision medicine is here to stay and, in the process, our task of understanding pharma/bio markets is becoming yet more complicated. This presentation, given by Simon Fitall at the recent...